Retinoic acid-induced downmodulation of telomerase activity in human cancer cells (Q38322870)

2 September 2017

title

Retinoic acid-induced downmodulation of telomerase activity in human cancer cells (English)

1 reference

2 September 2017

4

1 reference

2 September 2017

Igor A Sidorov

2

0 references

author name string

Xiaodong Xiao

series ordinal

1

1 reference

2 September 2017

Jennifer Gee

series ordinal

3

1 reference

2 September 2017

Dimiter S Dimitrov

series ordinal

5

1 reference

2 September 2017

publication date

1 October 2005

1 reference

Experimental and Molecular Pathology

2 September 2017

published in

1 reference

2 September 2017

volume

79

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

108-117

1 reference

The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Human telomerase and its regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Regulation of the human telomerase reverse transcriptase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

A survey of telomerase activity in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Direct activation of TERT transcription by c-MYC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Identification and characterization of rapidly dividing U937 clones with differential telomerase activity and gene expression profiles: role of c-Myc/Mad1 and Id/Ets proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.06.001

10.1016/J.YEXMP.2005.06.001

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference